These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21942413)

  • 1. Using engineered single-chain antibodies to correlate molecular binding properties and nanoparticle adhesion dynamics.
    Haun JB; Pepper LR; Boder ET; Hammer DA
    Langmuir; 2011 Nov; 27(22):13701-12. PubMed ID: 21942413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying nanoparticle adhesion mediated by specific molecular interactions.
    Haun JB; Hammer DA
    Langmuir; 2008 Aug; 24(16):8821-32. PubMed ID: 18630976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of Multivalent Nanoparticle Adhesion via Specific Molecular Interactions.
    Wang M; Ravindranath SR; Rahim MK; Botvinick EL; Haun JB
    Langmuir; 2016 Dec; 32(49):13124-13136. PubMed ID: 27797529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
    Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
    Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability engineering of scFvs for the development of bispecific and multivalent antibodies.
    Miller BR; Demarest SJ; Lugovskoy A; Huang F; Wu X; Snyder WB; Croner LJ; Wang N; Amatucci A; Michaelson JS; Glaser SM
    Protein Eng Des Sel; 2010 Jul; 23(7):549-57. PubMed ID: 20457695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering of stable bispecific antibodies targeting IL-17A and IL-23.
    Mabry R; Lewis KE; Moore M; McKernan PA; Bukowski TR; Bontadelli K; Brender T; Okada S; Lum K; West J; Kuijper JL; Ardourel D; Franke S; Lockwood L; Vu T; Frank A; Appleby MW; Wolf A; Reardon B; Hamacher NB; Stevens B; Lewis P; Lewis KB; Gilbertson DG; Lantry M; Julien SH; Ostrander C; Chan C; Byrnes-Blake K; Brody J; Presnell S; Meengs B; Levin SD; Snavely M
    Protein Eng Des Sel; 2010 Mar; 23(3):115-27. PubMed ID: 20022918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using avidin-mediated binding to enhance initial endothelial cell attachment and spreading.
    Bhat VD; Truskey GA; Reichert WM
    J Biomed Mater Res; 1998 Apr; 40(1):57-65. PubMed ID: 9511099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covalent and oriented immobilization of scFv antibody fragments via an engineered glycan moiety.
    Hu X; Hortigüela MJ; Robin S; Lin H; Li Y; Moran AP; Wang W; Wall JG
    Biomacromolecules; 2013 Jan; 14(1):153-9. PubMed ID: 23215344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A fully human scFv phage display library for rapid antibody fragment reformatting.
    Li K; Zettlitz KA; Lipianskaya J; Zhou Y; Marks JD; Mallick P; Reiter RE; Wu AM
    Protein Eng Des Sel; 2015 Oct; 28(10):307-16. PubMed ID: 25991864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production in yeast of pseudotype virus-like particles harboring functionally active antibody fragments neutralizing the cytolytic activity of vaginolysin.
    Pleckaityte M; Zvirbliene A; Sezaite I; Gedvilaite A
    Microb Cell Fact; 2011 Dec; 10():109. PubMed ID: 22171920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic strength of molecular adhesion bonds.
    Evans E; Ritchie K
    Biophys J; 1997 Apr; 72(4):1541-55. PubMed ID: 9083660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monospecific bivalent scFv-SH: effects of linker length and location of an engineered cysteine on production, antigen binding activity and free SH accessibility.
    Albrecht H; Denardo GL; Denardo SJ
    J Immunol Methods; 2006 Mar; 310(1-2):100-16. PubMed ID: 16499921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel synthetic trivalent single chain variable fragment (tri-scFv) construction platform based on the SpyTag/SpyCatcher protein ligase system.
    Alam MK; Brabant M; Viswas RS; Barreto K; Fonge H; Ronald Geyer C
    BMC Biotechnol; 2018 Sep; 18(1):55. PubMed ID: 30200951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An equilibrium model of endothelial cell adhesion via integrin-dependent and integrin-independent ligands.
    Chan BP; Bhat VD; Yegnasubramanian S; Reichert WM; Truskey GA
    Biomaterials; 1999 Dec; 20(23-24):2395-403. PubMed ID: 10614944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avidin-conjugated calcium phosphate nanoparticles as a modular targeting system for the attachment of biotinylated molecules in vitro and in vivo.
    van der Meer SB; Knuschke T; Frede A; Schulze N; Westendorf AM; Epple M
    Acta Biomater; 2017 Jul; 57():414-425. PubMed ID: 28552820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Combination of Structural and Empirical Analyses Delineates the Key Contacts Mediating Stability and Affinity Increases in an Optimized Biotherapeutic Single-chain Fv (scFv).
    Tu C; Terraube V; Tam AS; Stochaj W; Fennell BJ; Lin L; Stahl M; LaVallie ER; Somers W; Finlay WJ; Mosyak L; Bard J; Cunningham O
    J Biol Chem; 2016 Jan; 291(3):1267-76. PubMed ID: 26515064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of recombinant single-chain antibodies neutralizing the cytolytic activity of vaginolysin, the main virulence factor of Gardnerella vaginalis.
    Pleckaityte M; Mistiniene E; Lasickiene R; Zvirblis G; Zvirbliene A
    BMC Biotechnol; 2011 Nov; 11():100. PubMed ID: 22047084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability engineering of anti-EGFR scFv antibodies by rational design of a lambda-to-kappa swap of the VL framework using a structure-guided approach.
    Lehmann A; Wixted JH; Shapovalov MV; Roder H; Dunbrack RL; Robinson MK
    MAbs; 2015; 7(6):1058-71. PubMed ID: 26337947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A strategy to identify linker-based modules for the allosteric regulation of antibody-antigen binding affinities of different scFvs.
    Kellmann SJ; Dübel S; Thie H
    MAbs; 2017 Apr; 9(3):404-418. PubMed ID: 28055297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Avidin functionalized maghemite nanoparticles and their application for recombinant human biotinyl-SERCA purification.
    Magro M; Faralli A; Baratella D; Bertipaglia I; Giannetti S; Salviulo G; Zboril R; Vianello F
    Langmuir; 2012 Oct; 28(43):15392-401. PubMed ID: 23057670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.